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Highlights

“CEO Compensation and Corporate Risk:
Evidence from a Natural Experiment”



Convex managerial payoffs and firm risk are known to be correlated, but the direction of
causality remains unclear.



We exploit a change in risk to show how boards adjust incentives and how these incentives affect
managers’ risk-taking.



We find that firms reduce managers’ exposure to stock price movements after left-tail risk
increases.



Because the change in risk is unanticipated, we can also identify compensation’s effect on risktaking in the new environment.



Our results show that convexity from options can encourage risk-taking in corporate
investment and financing decisions.

1. Introduction
Option-based compensation for corporate executives has grown significantly over the past 30
years. It is commonly believed that stock options provide managers with incentives to take risks, but the
evidence remains unclear. Even less is known about how boards of directors design and adjust managers’
incentives in light of firms’ risk environments. The lack of definitive findings may seem surprising given
that the issue has been studied extensively. However, theoretical predictions are varied and overcoming
identification concerns remains challenging. In this paper, we take a new approach to these classic issues
in an attempt to augment our understanding of the relationship between risk and incentives.
Providing empirical evidence is important because theory’s prediction of how options affect risktaking incentives is ambiguous. On the one hand, options’ convex payoffs create an incentive to take risk
because managers share in the gains but not all of the losses. This intuition appears in Jensen and
Meckling (1976), Myers (1977), Smith and Stulz (1985), and Smith and Watts (1992).1 On the other
hand, Lambert et al. (1991) show that, because options contain a leveraged position in the firm’s equity,
options also have the potential to magnify a risk-averse manager’s exposure to the firm’s risk and thus
reduce the manager’s appetite for risk taking.2
Despite this theoretical ambiguity, there is a wealth of empirical evidence highlighting a positive
correlation between the use of options in pay and various measures of risk, such as stock-return volatility.
Work of this nature dates back to Agrawal and Mandelker (1987), if not earlier, and extends to Tchistyi et
al. (2011).3 For example, Guay (1999) shows that it is specifically the convexity of stock options that
determines the sensitivity of CEO wealth to equity risk. He finds that firms’ stock-return volatility is
positively associated with the convexity of the CEO’s full compensation package (including previously
granted stock and options), which has come to be known as “vega”.
See also Haugen and Senbet (1981), Bizjak et al. (1993), Gaver and Gaver (1993), and Guay (1999).
Option compensation may also increase or decrease the firm’s risk as a by-product of increasing managerial effort
(Kadan and Swinkels, 2008). See also Carpenter (2000) and Ross (2004).
3
Papers documenting a positive association between options and firm risk include DeFusco et al. (1990), Saunders
et al. (1990), Mehran (1992, 1995), May (1995), Tufano (1996), Berger et al. (1997), Denis et al. (1997), Esty
(1997a, 1997b), Jolls (1998), Schrand and Unal (1998), Aggarwal and Samwick (1999), Guay (1999), and Knopf et
al. (2002).
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Although this evidence suggests that risk-taking and vega are linked, identifying the causal effect
of option-based incentives on corporate risk-taking is difficult given the obvious endogeneity of the
relationship between options and risk. Because managers’ compensation is arguably designed in
anticipation of a particular risk environment, the possibility of reverse causality is hard to exclude.
Similar concerns about endogeneity plague the empirical literature on ownership concentration and firm
value (Demsetz and Lehn, 1985; Himmelberg et al., 1999; Palia, 2001).
There have been several attempts to solve this identification challenge. A number of papers
approach this question by estimating a system of simultaneous equations (see Coles et al., 2006; Rajgopal
and Shevlin, 2002; Rogers 2002). Although this approach makes progress by modeling the effects of vega
on decisions and vice versa, a fundamental concern remains in that the estimations in these papers require
arbitrary exclusion restrictions.4 A similar concern applies to Armstrong and Vashishtha (2012) and Shue
and Townsend (2013), who attempt to resolve the endogeneity problem using instrumental variables.5
Other recent work attempts to overcome the challenge by analyzing firms’ risk-taking following new
accounting rules that reduced options pay (Chava and Purnanandam, 2010; Hayes et al., 2012). These
new accounting rules, however, were known and debated for years in advance, undermining their
effectiveness as a natural experiment;6 further, because the rule change affected all firms at the same time,
these analyses lack a compelling counterfactual. In sum, although the estimation strategies in this
literature have grown more sophisticated and certainly made progress, important identification concerns
remain.
We take a step forward in addressing the identification challenge by exploiting changes in firms’
business environments that increase left-tail risk (also known as material risk) that can truly be classified
Coles et al. (2006) assume that the riskiness of the firm’s business environment does not affect project choice;
Rajgopal and Shevlin (2002) assume that cash balances and firm size are unrelated to firms’ risk choices; and
Rogers (2002) assumes that cash balances and stock variance are unrelated to firms’ hedging motives.
5
Armstrong and Vashishtha (2012) assume that cash balances, marginal tax rates, past stock returns, and past
profitability are unrelated to the proportion of firms’ overall risk that is systematic. Shue and Townsend (2013)
exploit the multi-year nature of firms’ fixed value and fixed number option grants to create instruments for when
managers’ holdings of options increase. This approach requires the assumption that boards set the type and/or
duration of these plans exogenously and without consideration for the consequences of these choices.
6
For example, Aboody et al. (2004) highlight that over one hundred firms voluntarily expensed stock options as
early as 2002 in anticipation of the 2005 adoption of FAS 123R, which was studied by Chava and Purnanandam
(2010) and Hayes et al. (2012).
4
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as exogenous and unanticipated. Left-tail risks are prevalent in practice and can take the form of
technological irrelevance, adverse regulatory changes, asset expropriation, and so on. The specific tail
risk we study is the risk of large legal liabilities and costly regulation. This setting provides an opening to
examine how managers respond to an increase in business risk as a function of their pre-existing equitybased incentives. The unanticipated change in risk allows us to exclude the possibility of reverse causality
between these pre-determined incentives and managers’ subsequent risk-related choices.
Our empirical analysis centers on a jump in tail risk that is created when a chemical to which a
firm’s workers have already been exposed is newly identified as a carcinogen. Discovery of a chemical’s
carcinogenicity increases the likelihood that a firm will need to spend large sums on legal fees, damage
payments, and insurance premiums in the future. By increasing the probability that cash flows will be
diverted to cover liability costs, this liability risk directly reduces the expected proceeds from new
investments that use the chemical as an input to production. The discovery can also create a debt
overhang problem, as described in Myers (1977). To the extent that future lawsuits or adverse regulatory
changes might consume the cash returned from a new investment, even if it does not use the carcinogen
directly, shareholders will be less willing to contribute the capital needed to fund the investment. Even if
no additional capital needs to be raised, shareholders might prefer for the firm to pay out existing cash
holdings, by increasing dividends or share repurchases, rather than to fund the new investment.
Gormley and Matsa (2011) confirm that such workplace exposures to carcinogens can increase a
firm’s downside risk and reduce shareholders’ willingness to fund new investments. Using data on
workplace exposures to known carcinogens, historical damage awards, and historical cash flows,
Gormley and Matsa find that a typical potential legal liability faced by firms appears to be around 5% of
assets and that such a shock would increase the median probability of distress among exposed firms by
30-fold. This underestimates the risk, as it does not account for the possibility of adverse future regulatory
changes.7 Consistent with a decline in shareholders’ desired investment, Gormley and Matsa find that
shareholders prefer for managers to pay out more cash after the tail risk increases.
An analysis of firms’ stock volatility in our sample (discussed later) also suggests that these exposures are salient;
the variance of stock returns for firms with an exposure increases by 60% after risk increases.

7
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Given the drop in desired investment, boards have reason to reduce managers’ exposure to their
firms’ risk. With fewer risky projects that shareholders are willing to fund, the boards no longer need to
provide risk-averse managers with as much pay convexity (vega) or sensitivity to firm value (known as
“delta”) as incentives to undertake risky investments (e.g., Hirshleifer and Suh, 1992; Smith and Watts,
1992). Other factors, discussed in Section 2.1, might also cause boards to decrease stock-based incentives
and lead managers to alter their financial exposure to the firm (e.g., by exercising options). While new
compensation awards can adjust quickly, managers’ overall sensitivities to stock price movements and
stock volatility are likely slower to adjust. Vesting schedules restrict the managers’ ability to reduce their
personal holdings, and it can be costly for firms to modify securities that have already been awarded.
Consistent with the tail risk reducing shareholders’ desire to fund new investments, we find that
boards respond by immediately adjusting compensation flows so as to reduce managers’ exposure to their
firms’ risks. Boards reduce the sensitivities of CEOs’ pay to changes in firm value (delta) and to changes
in the firm’s risk (vega) in the years immediately after the firm is exposed. In this way, the firms appear to
actively manage grants of new equity incentives, consistent with Core and Guay (1999). We also find that
managers seek to reduce their future exposure by exercising a greater number of stock options just after
the carcinogen is discovered. These results underscore concerns about reverse causality in prior studies of
CEO incentives’ effect on corporate risk-taking.
In contrast to our findings for compensation flows, however, we find that the sensitivity of the
manager’s overall compensation portfolio to firm risk is harder to modify quickly. We find that it takes
three to five years before the vega and delta of the entire compensation portfolio are significantly reduced.
That is, although boards react quickly to adjust new incentives in light of the increased risk, these changes
take time to shift the sensitivity of incumbent CEOs’ total firm-related wealth to firm risk. The opposite is
true for new CEOs, for whom the board gets a fresh start in fashioning incentives. Indeed, we find that
new CEOs have significantly lower portfolio vegas than do the CEOs they replace at the exposed firms
and lower portfolio vegas than do other newly appointed CEOs at unexposed firms.
To identify an effect of convexity on risk-taking behavior, we make use of a previously

4

unexplored effect of convexity on risk-taking incentives. Using a theoretical example in the framework of
Lambert et al. (1991), we show that the convexity of CEOs’ payoffs affects both the desired level of risktaking and how sensitive CEOs are to deviations from this level. Unlike the prior literature, we focus on
the latter effect of convexity. After an unanticipated increase in risk pushes a risk-averse manager above
his or her desired level of risk taking, the manager can benefit by reducing risk. However, when the
manager has a convex payoff, he or she gains less by reducing risk because the reduction lowers the
expected value of the convex payoff. Higher vega thereby provides the manager with the incentive to
reduce risk less aggressively.
The unanticipated increase in left-tail risk thus affords us a unique opportunity to identify a causal
effect of these incentives on managerial risk-taking. As illustrated by our theoretical framework, the level
of convexity immediately after risk increases affects risk-taking incentives in the new environment.
Because the manager’s compensation portfolio structure before the jump in tail risk is highly correlated
with his or her portfolio immediately afterwards, we can use this predetermined payoff structure to
analyze how option-based convexity affects managerial responses to an increase in risk, thereby avoiding
concerns about reverse causality.
Focusing on a short window of three years after risk increases and excluding any firm-years after
CEO turnover (because the pre-existing portfolio corresponds to a different CEO and is thus less
informative in those cases), we find that the convexity of a managers’ pre-existing, equity-based
incentives is positively related to the increase in their firms’ risk after a carcinogen is discovered. On
average, exposed firms’ stock variance increases by about 0.10 after the jump in tail risk, and exposed
firms whose CEOs face high vega see the largest increase in stock variance—a one standard deviation
greater vega is associated with a 50% larger increase in the stock variance. This finding suggests that
managers with more convex payoffs are less likely to take actions to offset the increase in left-tail risk and
provides the most definitive evidence to date that the convexity of managerial pay packages directly
affects managerial choices with respect to corporate risk.
We also explore the specific financing and investment choices managers make that affect firm
risk and find that these choices are also related to managers’ portfolios. Gormley and Matsa (2011) find

5

that the average firm responds to a jump in tail risk by reducing leverage and diversifying through
acquisitions of cash-rich firms. We explore heterogeneity in these responses. We find that CEOs with
high portfolio vegas reduce leverage less than CEOs in other exposed firms. Similarly, we observe
significantly less stockpiling of cash by CEOs with higher vegas. Convex payoffs also appear to make
CEOs less likely to engage in diversifying acquisitions and less aggressive in cutting back on risky
investments, as captured by smaller cuts in their firms’ R&D expenses.
Our findings do not appear to be driven by omitted variables, which could be a problem if factors
that are correlated with the initial choice of compensation structure also affect how a firm responds to the
increase in tail risk for reasons unrelated to compensation. For example, highly risk-averse managers
might respond more aggressively to reduce risk after tail risk increases. If firms compensate highly riskaverse managers with less option-based pay, then this might explain the observed correlation between
convexity and changes in financial and investment decisions. However, theory suggests more risk-averse
CEOs might actually be given payoffs that are more convex to mitigate the moral hazard problem arising
from their risk-aversion (e.g., Guay, 1999).8 Our results for vega are also robust to controlling for
manager fixed effects and interactions of exposure with various measures that are likely to be correlated
with managerial risk tolerance, including corporate financial vulnerability, external governance, and CEO
age and tenure.
Taken together, these results suggest that the structure of managerial compensation has important
effects on corporate responses to tail risk and that the convex payoffs provided by options do affect risktaking incentives. In particular, options can increase a firm’s overall risk by reducing managers’
incentives to undertake risk-reducing activities when facing a jump in left-tail risk. Relative to stock, risktaking incentives from options’ convexity appear to reduce the sensitivity of a manager’s expected utility
to deviations from the manager’s desired level of risk.
Our paper addresses two distinct, but connected, questions regarding managerial compensation
and risk: how do firms’ risky investment opportunities affect boards’ choices regarding stock-based pay
On the other hand, firms might need to offer more risk-averse CEOs less convex payoffs to attract them in the first
place.

8
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and how do convex payoffs affect managers’ risk-taking incentives? The interconnectedness of these
questions makes it challenging to answer either question. Identifying how boards adjust pay is difficult
given the lack of exogenous changes in firms’ risky investment opportunities. As a result, prior research
typically relies on market-to-book ratios as a measure of growth opportunities (e.g., Smith and Watts,
1992; Core and Gauy, 1999) or on regulatory changes that affect managers’ incentives to invest in risky
projects (Cohen, Dey, and Lys, in press). Likewise, identifying how convex payoffs affect managers’
risk-taking incentives is complicated by the lack of exogenous changes in such payoffs. Our paper takes a
new approach to these two questions by analyzing an exogenous increase in tail risk that directly affects
shareholders’ investment opportunities.
The remainder of the paper is organized as follows. Section 2 discusses how managers’ portfolios
respond to tail risk and illustrates how shocks to tail risk can be used to identify options’ effect on
managerial risk-taking. Section 3 discusses our empirical setting, data sources, and identification strategy.
Section 4 analyzes how boards adjust equity-based incentives in response to an unanticipated change in
tail risk. Section 5 examines the managers’ responses to increased risk as a function of their existing
compensation contract. Section 6 concludes with a discussion of the broader implications of our work.
2. Theoretical framework
This paper develops a novel way to use unanticipated shocks to business risk to examine how the
structure of managers’ compensation portfolios both responds to changes in firms’ background risk and
affects managerial risk-taking. In this section, we first discuss why managers’ portfolios might respond to
changes in risk and why these responses pose an identification challenge to many estimates in the existing
literature. We then show how unanticipated increases in risk can be used to identify both this response
and compensation’s effect on risk taking.
2.1. Endogeneity of managers’ compensation portfolios to background risk
The riskiness of firms’ investment opportunities is widely thought to be an important determinant
of managers’ compensation. Firms often face investment opportunities that have positive net present
value but feature significant idiosyncratic risk. Because risk-averse managers may be reluctant to take
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such risky projects, boards can use convex payoffs to induce managers to do so (e.g., Hirshleifer and Suh
1992; Dittmann and Yu 2011; Edmans and Gabaix 2011). This motive for providing convexity is
strongest for firms with many risky investment opportunities, including growth options (Guay 1999), and
thus might lead to a positive association between convexity and firm risk.
In our empirical analysis, we examine how managers’ portfolios respond to the increase of a
particular type of risk, left-tail risk. Unlike a mean-preserving increase in risk, which maintains the net
present value of existing projects, an increase in left-tail risk decreases the expected cash flows (and
NPV) by boosting the probability of a very negative outcome. The left-tail risk reduces the chance that
shareholders will receive proceeds from the firm’s future investments and affects the manager personally
through any undiversified wealth that is tied to the value of the firm. As such, a left-tail risk will likely
lead both boards and managers to adjust the portfolio vega and the portfolio delta.
Boards have multiple reasons to decrease managers’ portfolio vega and portfolio delta after lefttail risk increases. By reducing shareholders’ expected cash flows from new investments, the left-tail risk
reduces shareholders’ willingness to pursue marginal projects, thereby reducing the need to provide a
risk-averse manager with an incentive to undertake as many risky investments.9 In this scenario, boards
have reason to reduce managers’ compensation vega. The decrease in desired investments also reduces
the need for delta (Smith and Watts 1992), as do other factors. Risk-averse executives may require a
greater premium for holding stock-based pay, which could also lead firms to shift compensation to other
forms. Finally, reducing managers’ exposure to firm risk, by reducing their stock-based pay, can also
mitigate agency conflicts arising from managers’ risk aversion (Jensen and Meckling 1976; Amihud and
Lev 1981; Holmström 1999), which are particularly acute in the presence of left-tail risk (Gormley and
Matsa 2011).
Managers also have a personal incentive to limit their financial exposure to their firms’ risk. Lefttail events, such as bankruptcy and employment loss, can lead to severe personal losses, including the loss
of private benefits, reputation, and wealth tied to the firm. The most direct way managers can limit their
exposure to these risks is to alter their financial portfolio (e.g., by exercising options or selling
Indeed, Gormley and Matsa (2011) find evidence that shareholders prefer managers to pay out the excess cash
through dividends and stock repurchases following the increase in tail risk described in Section 3.
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unrestricted stock). To the extent that CEOs influence their own pay, they might also shift their
compensation away from stock and options. These changes may lower both vega and delta. Furthermore,
managers can modify the firms’ risk directly by altering corporate investment (Gormley and Matsa,
2011).
These effects of risk highlight the endogenous nature of the managers’ compensation contracts.
Because firms’ risk environment affects the structure of managers’ contracts and because option-based
pay may in turn affect risk-taking incentives, it is difficult to identify either causal effect by simply
comparing measures of risk-taking to managers’ portfolio vega and delta. As we describe next,
unanticipated shocks to tail risk can be used to overcome these identification challenges.
2.2. Identification based on shocks to business risk
It is straightforward to see how an exogenous increase in business risk can be used to identify
how firms’ risk affects the structure of managers’ compensation portfolios. Under plausible assumptions,
the shock to business risk also allows us to identify how the structure of managers’ compensation
portfolios, including their convexity, affects managers’ risk-taking.
To illustrate how we identify the effect of convex payoffs on risk-taking, we derive the expected
utility and marginal expected utility with respect to risk for a manager with different portfolios. Following
Lambert et al. (1991), we model a portfolio as a combination of cash, stock, and options that provides a
risky payoff, Z(P), at the end of the period, and this payoff is a function of the firm’s stock price, P. This
portfolio can be thought of as the combination of both past and current compensation paid to the manager
by the firm’s shareholders, along with the manager’s outside wealth (including cash, real estate, or other
investments), which is not tied to the firm’s performance. The stock price P is assumed to be a random
variable with cumulative probability distribution F(P) and density function f(P), and is bounded below by
zero. Letting U(x) represent the manager’s utility when his or her total payoff is x, the manager’s expected
utility can be expressed as


 U  Z ( P)  f ( P)dP.
0
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(1)

In this framework, we analyze a manager’s expected utility under different portfolios of stock and
options. We assume the manager has a power utility function with a coefficient of relative risk aversion of
two. Similar to the Black-Scholes model, we assume that the firm’s stock return follows a lognormal
return process, and following Lambert et al. (1991), we assume an initial stock price of $50, annual
expected return of 0.10 per year, and an annual variance of returns σ2.
For simplicity, we analyze the manager’s expected utility under two possible portfolios: one with
only options and the other with only stock. The options portfolio contains 50,000 options. The options are
assumed to expire in ten years and have a 20 percent probability being in the money at expiration. The
stock portfolio contains 2,500 shares of stock. The particular numbers of options and shares ensure that
the two portfolios provide the manager with the same expected utility when at the risk level that
maximizes expected utility; in other words, the manager’s participation constraint is satisfied equally by
the two portfolios. In both cases, the portfolio accounts for one-third of the manager’s total wealth. We
use a positive affine transformation to rescale the utility functions so that the maximum utility is equal to
ten. Figure 1 plots the manager’s expected utility as a function of the firm’s stock return variance under
the two different portfolios.
The two expected utility functions in Figure 1 illustrate how options’ convex payoffs (vega) can
influence the manager’s optimal level of risk-taking. As shown in Figure 1, the level of stock variance
that maximizes a manager’s expected utility depends on the manager’s portfolio; the optimal stock
variance for the manager with the options portfolio is greater than it is with the stock portfolio. The
manager’s optimal stock variance is chosen to balance incentives from the payoff’s convexity and his or
her risk aversion. For a given increase in risk, the increased value of a convex portfolio increases the
manager’s expected utility, but risk aversion reduces it. At low levels of risk, the gains in expected utility
from the portfolio’s convexity exceed the losses from risk aversion, providing a net incentive for the
manager to take on greater risk. The prior literature has focused on this relationship between the amount
of convexity in the payoff structure (vega) and the desired level of risk-taking.10

Although the options portfolio increases risk-taking incentives in this example, this need not always be the case.
As shown by Lambert et al. (1991), Carpenter (2000), and Ross (2004), options—particularly those deep in-themoney—also make a manager’s wealth sensitive to stock price movements (i.e., options also increase delta), which
can reduce risk-taking incentives.
10
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A portfolio’s convexity also affects the “risk-curvature” of the manager’s expected utility, where
risk-curvature is defined as the manager’s marginal utility with respect to risk. For example, note the riskcurvature of the manager’s expected utility around the optimal levels of risk in Figure 1; the expected
utility of the manager with options is flatter around the peak than that of the manager with stock. The
difference in risk-curvature arises from the convexity-risk aversion tradeoff. An increase in volatility
reduces a manager’s expected utility because the manager is risk averse, but convex compensation
mitigates this reduction in expected utility because the convexity boosts the expected value of the
compensation as volatility increases. The same intuition holds in reverse for reductions in volatility; a
manager with more convex payoffs experiences smaller changes in expected utility when risk decreases.11
Our paper exploits this novel connection between payoff convexity and risk-curvature to design
an empirical test that links managers’ compensation convexity to risk-taking. Rather than examine the
relationship between convexity (vega) and the level of risk-taking directly, as in the prior empirical
literature, our identification strategy instead examines the relationship between convexity and the change
in risk-taking after firms’ risk unexpectedly increases. Put in terms of the manager’s expected utility as a
function of risk (Figure 1), we relate risk-taking behavior to convexity-driven differences in riskcurvature at the peak rather than to convexity-driven differences in the location of the peak. Our thought
experiment is as follows: assume that a manager has already chosen the level of risk that maximizes his or
her expected utility given the current compensation arrangement; what happens when the firm’s risk
environment unexpectedly changes?
When the risk environment changes, the convexity of the manager’s potential payoffs also
changes. Theoretically, the effect of an increase in left-tail risk on the convexity of an option’s payoff
structure is ambiguous. The partial derivatives of vega with respect to volatility and stock price, where
vega is measured as the sensitivity of the value of the managers’ options to stock price volatility
(following Core and Guay, 2002), can be positive or negative depending on other parameters. Strictly
Like the effect of options on a manager’s desired level of risk, the effect of options on a manager’s sensitivity to
deviations in risk is also theoretically ambiguous because options provide exposure to stock price movements (i.e.,
delta) in addition to convexity. In our example, the convexity effect dominates.
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speaking, the stock portfolio’s convexity is also affected by the increase in tail risk, but the effect is small
and will not be picked up by this definition of vega (Guay, 1999; Core and Guay, 2002).
The convexity of the manager’s payoffs prior to the unexpected change in risk, however, is a
positive predictor of convexity immediately after the change in risk. In Figure 2, we plot the vega for each
portfolio after risk changes. To match our empirical setting, we model this change in risk as an increase in
left-tail risk. (The analysis is similar when the increase in stock return variance is mean-preserving; see
Appendix B). Specifically, we examine an increase in the probability of a stock price realization below
$10; we plot the effect of increases in this probability of between zero and five percentage points. A five
percentage point increase in the probability of a price below $10 roughly represents a doubling of that
probability.12 Our analysis is robust to varying the size of the shock in both scope (the price below which
realization probabilities increase) and scale (the size of the probability increase). As shown in Figure 2,
the vega of the option portfolio declines after left-tail risk increases but remains greater than the vega of
the stock portfolio, which equals zero irrespective of the tail-risk.
This difference in the portfolios’ convexity affects risk-taking incentives after tail risk increases.
Figure 3 plots the manager’s marginal expected utility with respect to volatility after left-tail risk
increases. Marginal expected utility is plotted separately for the stock and option portfolios. The
manager’s marginal expected utility is negative for both portfolios but is smaller in magnitude for the
more convex portfolio. In other words, the convex portfolio provides the manager with less incentive to
reduce the firm’s stock price volatility after risk increases. This difference in incentives relates to the riskcurvature of expected utility around its peak and to the underlying convexity-risk aversion tradeoff. A
risk-averse manager, irrespective of his or her portfolio, gains from reducing risk, but this gain is less
when reducing risk also reduces the expected value of convex payoffs. If it is costly or simply difficult to
adjust the firm’s risk, this effect of convexity makes the manager less responsive to the firm’s changing
risk environment.

An increase in left-tail risk also reduces a firm’s overall value and stock price. In this example, a five percentage
point increase in the probability of a price below $10 reduces the firm’s stock price by about 5.25%.
12
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As illustrated by Figures 2 and 3, the pre-existing differences in convexity largely persist after
risk increases and affect managers’ risk-taking incentives. Our empirical tests, therefore, relate managers’
responses to their pre-existing pay structure. We measure their pay structure prior to risk unexpectedly
increasing because these incentives are predetermined and highly correlated with their incentives
immediately afterwards, which we do not observe directly in our empirical setting. The ex post vega and
delta that we do observe might already be affected by managers’ endogenous responses, including
adjustments to financial leverage, cash holdings, R&D, and acquisitions. By affecting firm risk, these
managerial actions also affect the convexity of managers’ own payoff structure, thereby making it
difficult to identify the direction of causality when relating managers’ actions to the ex post level of
convexity.13
By focusing on how vega is related to responses to unanticipated increases in risk, rather than
absolute levels of risk-taking, our empirical approach allows us to avoid the concerns about reverse
causality that plague the existing literature. Traditionally, researchers have compared the vega of
managers’ portfolios to measures of firm risk, but as shown in Section 4, the firms’ risk environment
influences boards’ choices regarding managers’ equity-based pay. Absent exogenous shocks to managers’
option-based incentives, this reverse causality poses an identification challenge for the traditional
estimation approach. Because our approach focuses instead on how vega affects responses to increased
risk, avoiding concerns about reverse causality only requires that the increase in risk be unanticipated.
Thus, our approach to identify convexity’s effect on risk-taking requires the same assumptions as
would be required to use the ex ante payoff structure as an instrument for the unobserved ex post payoff
structure that motivates managers’ risk-taking:14
1) The portfolio vega (portfolio delta) immediately prior to risk increasing is positively
correlated with the portfolio vega (portfolio delta) immediately afterward.
Figures 2 and 3 also illustrate why it is appropriate to focus on ex post levels of vega rather than on the changes in
vega caused by the increase in left-tail risk. Even though vega decreases more when the manager holds options
(Figure 2), the manager has less incentive to reduce risk when he or she holds options (Figure 3), because the
manager still has a higher vega after risk increases than when he or she holds stock.
14
Note that we cannot use the increase in liability risk itself as an instrument for vega and delta, because the increase
itself boosts stock volatility, thereby violating the exclusion restriction.
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2) The increase in left-tail risk is unanticipated.
3) The portfolio vega and portfolio delta immediately prior to risk increasing are not
correlated with variables that also affect companies’ responses to the increased risk.
The first assumption allows us to use the ex ante portfolio vega and portfolio delta as proxies for the
unobserved ex post portfolio vega and portfolio delta that drive risk-taking incentives. The second
assumption enables us to rule out reverse causality, and the third assumption pertains to omitted variables.
Unlike the traditional empirical approach, which must assume the absence of unobservable factors that
affect both managers’ portfolios and firms’ risk, our assumption is narrower. In order for an unobserved
variable to be problematic in our setting, it must affect both managers’ portfolios and how firms respond
to unanticipated changes in risk. We evaluate and rule out potential confounders in robustness tests
reported in Section 5.

3. Empirical setting
In this paper, we analyze left-tail risk that is created when a chemical to which a firm’s workers
have already been exposed is newly identified as a carcinogen. The discovery increases both the liability
and regulatory risks of the firm. Using data on workplace exposures to known carcinogens, historical
damage awards, and historical cash flows, Gormley and Matsa (2011) find that a typical legal liability
faced by firms with such workplace exposures is around 5% of assets, and that such a shock would
increase the median probability of distress among exposed firms by 30-fold. The possibility that future
regulation might limit the use of these chemicals and significantly increase a firm’s cost of doing business
further increases the risk of future distress. See Gormley and Matsa (2011) for a more detailed description
of the liability and regulatory risks associated with workplace exposures and why firms cannot easily
insure or protect themselves from these risks.
Identifying workers’ exposure to newly identified carcinogens requires the combination of
information on (1) scientific discoveries related to chemical carcinogenicity and (2) which firms use these
chemicals. Following Gormley and Matsa (2011), we use the National Toxicology Program’s (NTP)
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Report on Carcinogens (RoC) for information about the timing of discoveries and the National
Occupational Exposure Survey (NOES) to identify firms in which workers were likely to have been
exposed to these chemicals. We considered various other data sources, including International Agency for
Research on Cancer monographs, California Proposition 65, and the Environmental Protection Agency’s
Integrated Risk Information System. We chose to rely on the RoC because each edition is comprehensive,
because it provides a long time series, and because U.S. law requires firms to monitor the list. For
example, firms are required to warn employees about their exposure to substances that are included in the
RoC [U.S. Government Regulation 29 CFR, parts 1910.1200(b)(1) and (d)(4)]. Although the RoC is not
updated annually, Gormley and Matsa (2011) find that firms respond only after chemicals are added to
the list.
We determine whether a firm is affected by the listing of a newly classified carcinogen based on
the firm’s SIC code in Compustat in the year prior to each new listing.15 We consider a firm to be affected
if it operates in a 4-digit SIC code in which at least 5% of workers were observed to be exposed to the
carcinogen in the NOES. The 5% cutoff captures 32 unique chemical additions to the RoC after 1983 and
roughly the top third of observed exposures at the industry level, corresponding to the discoveries that are
most likely to result in increased legal liability and future distress.16
Our data on firms’ financials are from Compustat, and our data on executive compensation are
from Yermack (1995) and Execucomp. Yermack (1995) covers the approximately 800 firms listed by
Forbes magazine as among the 500 largest U.S. public corporations in the years 1984–1991, and
Execucomp covers about 3,000 S&P 1,500 firms in the years 1992–2008. Our main measures of a CEO’s
payoff structure are the sensitivities of the CEO’s firm-related wealth to stock price movements and to
stock price volatility. We calculate a manager’s sensitivity to stock price movements (delta) from his or
her portfolio of stock and options using the Core and Guay (2002) definition—the dollar change in wealth
To accomplish this, we first convert the NOES data, which are reported using the SIC-1972 coding scheme, to the
SIC-1987 coding scheme used by Compustat, by applying an employee-weighted concordance table from the
Bureau of Labor Statistics (1989). We then determine which firms were affected by an increase in tail risk based on
Compustat’s historical measure of a firm’s industrial classification.
16
We use a lower cutoff than do Gormley and Matsa (2011) because of the relatively small number of exposed firms
for which compensation data are available.
15
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experienced by the manager for a 1% increase in the firm’s stock price. We calculate the sensitivity to
stock price volatility (vega) using the dollar change in wealth experienced by the manager for a 0.01
increase in the volatility of a firm’s stock price. This measure of sensitivity has been used to measure a
manager’s incentive to take risks (e.g., Guay, 1999; Habib and Ljungqvist, 2005). Both incentive
measures are expressed in thousands of dollars. Details on the construction of all variables are in
Appendix A.
To ensure a consistent sample of observations across specifications, we exclude observations with
missing values for the inputs necessary to calculate the manager’s delta and vega in the year prior to a
chemical being added to the RoC. In all, 143 firms with both financial and compensation data are affected
by a newly identified carcinogen, and these increases in tail risk occur for different firms in 1985, 1989,
1991, 2000, and 2004. These firms operate in 43 different 4-digit SIC industries and span 21 of the 48
Fama and French (1997) industries. (Fama-French industries are collections of 4-digit SIC industries that
are meant to represent broader industry categories.)
For each new chemical listing in the RoC, we construct a comparison group of unaffected firms
(firms without observed exposures to any newly listed carcinogens) that were present in the same FamaFrench industry classification as one of the affected firms. To ensure an adequate control sample in each
industry, we drop both affected and unaffected observations in Fama-French industries in which there is
not at least one unaffected firm for every ten affected firms. (Our findings are robust to using other
exclusion thresholds.) This yields a comparison sample of 341 unexposed firms in 82 SIC industries.
Firms with exposures to the newly identified carcinogens are strikingly similar to our sample of
unexposed firms before the listing of a new carcinogen. Ex ante characteristics of firms with exposures
are reported in column (1) of Table 1, and the ex ante characteristics of firms without exposures are
reported in column (2). Even though we match firms based only on Fama-French industries, the two
groups are similar in average stock variance, size, market-to-book, and profitability. Annual
compensation and equity-based incentives, as measured by log total pay and the fraction of pay given as
options, are also similar across the two groups of firms. The differences in delta and vega of managers’
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full portfolio of options and stock are less than one-tenth and one-eighth of a standard deviation,
respectively.17 As shown by the p-values reported in column (3), we are unable to reject the null
hypothesis that exposed and unexposed firms are similar in all of these dimensions before risk increases.
As in Gormley and Matsa (2011), the use of the NOES likely introduces a degree of measurement
error in our ability to identify firms with potential exposures, possibly leading us to underestimate the true
effect of tail risk. There are two main measurement issues. First, the NOES only provides data on
exposures at the 4-digit industry level; firm-level data is not available. Our subsequent analysis implicitly
assumes that all firms in the industry are affected and calculates the average effect. If not all firms in the
industry are affected, then we are underestimating the true average effect of the increase in tail risk.
Second, firms may have stopped using a dangerous chemical after the NOES was completed in 1983 but
before the chemical’s listing in the RoC. Whereas firms would still be liable for past exposures, the
increase in liability risk would be smaller in such cases. Despite these measurement concerns, Gormley
and Matsa (2011) present evidence to suggest that the NOES indeed captures exposures that later become
significant liability and regulatory risks.
An analysis of firms’ stock volatility suggests that the liability and regulatory risks associated
with these exposures are salient. Figure 4 plots the annualized daily variance of exposed and unexposed
firms’ stock returns, relative to the year before a new chemical is added to the RoC. Whereas exposed and
unexposed firms’ stock variances track each other quite closely before the carcinogen comes to light, they
diverge sharply afterward with stock variance increasing by about 60% among exposed firms. The sharp
change in volatility after a chemical is added to the RoC confirms that new RoC listings correctly capture
the timing of increases in business risk.
Gormley and Matsa (2011) analyze corporate responses to this increase in risk. They find that
firms, especially those with weak balance sheets, tend to respond to such risks by acquiring large,
unrelated businesses with relatively high operating cash flows. The diversifying growth is primarily
funded with equity, thereby reducing overall financial leverage, and appears to be motivated primarily by
managers’ personal exposure to their firms’ risk in that the growth has negative announcement returns
17

The standard deviations of portfolio delta and portfolio vega are 2,179 and 120.8, respectively.
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and is related to firms’ external governance, institutional ownership, and inside ownership, as measured
using the share of the firm’s stock held by the firm’s management team. The analysis here directly
examines the role of CEOs’ compensation, its convexity, and its effect on risk-taking incentives. In
particular, we examine how quickly boards change the structure of CEOs’ compensation to reflect the
new risk environment, and we exploit CEOs’ pre-existing stock and options holdings (that were awarded
before the manifestation of the tail risk) to analyze whether the convexity of managers’ payoff structure is
related to risk-taking incentives.
4. How business risk affects the structure of managerial compensation
To examine how compensation structures respond to increased tail risk, we compare changes in
the exposed and unexposed firms’ managers’ compensation structures after a new carcinogen is listed in
the RoC. We first analyze the immediate impact of business risk on the structure of managers’ annual
compensation (which we will refer to as compensation “flows”) and on managers’ decisions to exercise
options. We then analyze the long-term impact on managers’ overall portfolio vega and portfolio delta
and the impact on the starting-year vega and delta of newly hired managers.
4.1. Effects of exposure on flow vega, flow delta, and options exercised
To examine how the structure of compensation flows respond to increased tail risk, we construct
a cohort of exposed and unexposed firms using firm-year observations for the three years before and the
three years after the listing for each year that new carcinogens are listed. We start with three-year
windows to examine how compensation changes in the immediate aftermath of the increase in tail risk.
Firms are not required to be in the sample for the full six years around the listing. We then pool the data
across cohorts (i.e., across all new carcinogen listings) and estimate the average treatment effect using a
stacked difference-in-differences estimation similar to Gormley and Matsa (2011). Specifically, we
estimate the following firm-panel regression:
flow
Incentivesijct
 0  1 Exposure jct  tc   ic   ijct ,

(2)

flow
is one of several dependent variables of interest related to the structure of the chief
where Incentivesijct
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executive’s compensation flow for firm i in year t, and Exposure is an indicator that equals one if at least
5% of employees in cohort c and industry j were observed to be exposed in the NOES to a known RoClisted carcinogen as of year t. For an exposed firm, this indicator changes from 0 to 1 when the chemical
is identified as a carcinogen. We include firm-cohort fixed effects,  ic , to ensure that we estimate the
impact of exposure after controlling for any fixed differences between firms; we include year-cohort fixed
effects, tc , as a non-parametric control for any secular time trends. Gormley and Matsa (in press) show
that such fixed effects, rather than other ad hoc transformations of the dependent variable commonly used
in the literature, are the correct way to control for unobserved group heterogeneities. We allow the firm
and year fixed effects to vary by cohort because this approach is more conservative than including simple
fixed effects. In our baseline specification, we deliberately do not control for any time-varying accounting
variables because these variables are likely to be affected by the increase in tail risk, and their inclusion
could thus confound estimates of 1 .18 In any event, the results are robust to the inclusion of standard
controls, as reported in the tables below. To account for potential covariance among firm outcomes within
the same 4-digit SIC code and over time, we adjust the standard errors for clustering at the industry level.
After tail risk increases, there are two primary ways for a manager’s financial exposure to the
firms’ stock price and volatility to change: changes initiated by the company’s board and changes
initiated by the manager. First, the board can modify the options and stock components of the manager’s
current pay. We measure these adjustments using the vega and delta of managers’ current year
compensation and refer to these sensitivities as “flow vega” and “flow delta” for short. Second, the
manager can modify his or her exposure by exercising vested options and/or selling unrestricted stock.
We examine both types of changes in Table 2.
We find that boards do in fact modify the incentive structure of managers’ annual compensation
after tail risk increases. Specifically, they reduce the annual compensation’s sensitivities to both return
volatility and price. Controlling only for firm-cohort and year-cohort fixed effects, the CEOs’ flow vega
Because the increase in tail risk is exogenous, β1 in Eq. (2) measures the change in the dependent variable caused
by the increased tail risk. If we include endogenous controls, then β1 might be biased (Angrist and Pischke, 2009,
pp. 64–66).
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decreases, on average, by $7,600 per 0.01 increase in the firm’s stock return volatility (column 1; p <
0.05), and the flow delta decreases by about $12,900 per 1% increase in equity value (column 4; p <
0.01). The declines in flow vega and flow delta are robust to additional controls for firm size, CEO tenure,
and the CEO’s total cash compensation (columns 2 and 5).19 These decreases are also not driven by CEO
turnover; significant drops in both flow incentives remain after excluding ex post observations from both
the affected and comparison samples for which a different CEO is in control than in the year before the
listing (columns 3 and 6).
The declines in vega and delta are consistent with boards responding to the decline in risky
investment opportunities that shareholders wish to pursue. Because the increase in left-tail risk reduces
the expected cash flows from many risky investments, boards have reason to use less convex payoffs and
fewer stock-based incentives. The declines could also reflect other considerations, as discussed in Section
2.1.20
Managers of exposed firms also take actions to directly reduce their own financial exposure to
their firms’ risk. In the three years after tail risk increases, CEOs of exposed firms sharply increase the
value of options they exercise relative to CEOs of unexposed firms by more than $1 million, after
controlling for size, tenure, and cash compensation (column 8; p < 0.01). The increase in the value of
options exercised is robust to excluding observations for which a different CEO is present than in the year
before the RoC listing (column 9). In unreported results, we also find a decrease in the number of shares
owned by managers of exposed firms of about 30,000, suggesting these managers may be selling shares
in addition to exercising options, but the estimate is noisy and not statistically significant (the standard
error is about 85,000 shares).

Our control variables in this and later specifications follow Hayes et al. (2012). All of the variables are defined in
Appendix A.
20
Some caution is warranted before interpreting the decline in convexity after risk increases as evidence that boards
in our sample want CEOs to engage in risk-reducing activities, like diversifying acquisitions, rather than just to
curtail future investments. Further analysis finds that the reduction in vega is greater among managers with an
above-median vega. Even after the reductions, these managers’ average vega remains higher than that of other
exposed firms and discourages these managers from engaging in the value-destroying, risk-reducing activity
documented in Gormley and Matsa (2011).
19
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The timing of these changes coincides with the increase in tail risk. Figure 5 plots point estimates
from a modified version of Eq. (2), where we allow the effect of Exposure to vary by year from three
years before risk increases until three years afterward.21 The relative changes in flow vega (flow delta) are
in the top (middle) panel. There is no indication of a decrease in flow vega or flow delta prior to the
increase in tail risk, but afterward, firms with exposure to a newly identified carcinogen tend to reduce
their CEO’s flow vega and flow delta relative to other firms. These reductions begin the year risk
increases and stay lower thereafter.
The timing of the increase in options exercised by managers at exposed firms, presented in the
bottom panel of Figure 5, is striking as well. The value of options exercised is practically flat in the years
before tail risk increases; before the chemical is added to the RoC, managers of exposed firms appear no
more likely than do managers of other firms to increase or decrease the number of options exercised.
Then as soon as risk increases, managers of firms with exposure to a newly identified carcinogen start
exercising options more than do other managers. These managers exercise an additional $2 million in
options relative to managers of similar unexposed firms in the year that risk increases and exercise an
additional $1 million the following year.
The precise timing of these exercise decisions and the changes in flow vega and flow delta
suggest that they are in fact caused by the increase in tail risk, rather than by any omitted characteristic
related to the manager, firm, or industry. The timing of these changes also confirms that firms and their
managers did not anticipate the chemicals’ addition to the RoC; if anticipated, we would expect the
incentive changes and option exercising to begin prior to the chemical being added to the RoC.
These findings highlight the potential for reverse causality in prior studies of CEO incentives and
their effect on corporate risk-taking. A firm’s choice to use stock- and option-based incentives depends on
its risk environment, so a correlation between equity-based incentives and firm risk may reflect the effect
of the firm’s risk environment on its choice of incentives or vice versa. This joint determinedness of
incentives and a firm’s risk raises concerns about previous identification strategies that implicitly or
explicitly assume the firm’s risk environment has no effect on the choice of incentives.
This analysis examines a longer panel of five years before Exposure. The point estimates reported in Figure 5 are
estimated relative to the excluded years T – 4 and T – 5.
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4.2. Long-term effects of exposure on portfolio vega and portfolio delta
We next analyze the long run changes in the vega and delta of managers’ accumulated
compensation portfolios—what we call the “portfolio vega” and the “portfolio delta.” Table 3 presents
results from regressions examining the overall change in portfolio vega and portfolio delta in the years
after risk increases. Specifically, we estimate the following firm-level regression:
portfolio
Incentivesijcportfolio
[ t T  k ]  Incentivesijc[ t T 1]   1 Exposure jc[ t T  k ]   c   ijc

,

(3)

portfolio
where Incentivesijcportfolio
[ t T  k ]  Incentivesijc[ t T 1] is the change in portfolio vega or portfolio delta from the year

before a chemical is added to the RoC (i.e., t = T - 1) to k years after the chemical is added (t = T + k)
for the CEO of firm i in industry j and cohort c; Exposurejc[t=T+k] is defined as before; and δc is a cohort
(or, equivalently, year) fixed effect. To focus on how the shift in flow vega, flow delta, and exercising
activity affect the portfolio vega and portfolio delta of the existing CEO, we exclude observations in
which the CEO in year T + k was not in office in year T - 1. We analyze the change in portfolios for
newly appointed CEOs below. The standard errors are again adjusted for clustering at the industry level.
We find that the changes in the composition of new compensation awards and in managers’
exercising behavior seem to lower CEOs’ portfolio vega or portfolio delta three years after tail risk
increases, but the declines are not statistically significant. Our point estimate for the three-year decrease
in portfolio vega is about $25,000 per 0.01 increase in a firm’s stock volatility, which is about one-fifth of
a standard deviation (Table 3, column 1). The three-year decrease in portfolio delta is about $180,000 per
1% increase in equity value, or about one-fourth of a standard deviation, for managers of exposed firms
relative to other managers and relative to their own deltas before risk increases.
Decomposing the exposed firms’ vega after risk increases illustrates the sources of these changes
and the relative importance of already-granted stock and options. CEOs’ portfolio vega after tail risk
increases can be written as the combination of three components:
pre
flow
exercised
vegaijcportfolio
[ t T  k ]  vegaijc[ t T  k ]  vegaijc[ t T  k ]  vegaijc[ t T  k ] ,

(4)

where vegaijcpre[t T  k ] is the vega in year T + k of the compensation portfolio held by CEO i in industry j and
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cohort c in year T – 1, vegaijcflow
[ t T  k ] is the vega of options accumulated through the CEOs’ annual
compensation flows between years T and T + k, and vegaijcexercised
[ t T  k ] is the vega of options exercised by the
CEO between years T and T + k. To estimate how much each of these sources contribute to the changes in
vega, we restrict attention to the Execucomp sample, due to data availability. Further details on these
calculations are in Appendix C.
We find some evidence of exposed CEOs’ portfolio vega decreasing after risk increases, similar
to our findings in the full sample. Figure 6, Panel A plots the average portfolio vegas for managers of
exposed and unexposed firms. While there appears to be no change in portfolio vega among unexposed
firms over the period, the exposed firms’ portfolio vega drops in the year that tail risk increases and
continues to decrease in subsequent years. The cumulative decline in year T + 2 is about one-third of a
standard deviation, but similar to the full sample (reported in Table 3, Column 1), it is not statistically
significant at conventional levels (p = 0.15).
The breakdown of the portfolio vega into its three components reveals the importance of
managers’ pre-existing portfolio after tail risk increases. As shown in Panel B of Figure 6, the pre-existing
portfolio still accounts for almost half of exposed CEOs’ portfolio vega three years after tail risk
increases. The continued importance of the pre-existing portfolio may not be surprising in that vesting
schedules restrict managers’ ability to exercise their options and because it is costly for firms to modify
securities that have already been awarded. The ongoing influence of the pre-existing portfolio suggests
that the decline in flow vega and flow delta described above take time to significantly affect the portfolio
vega and portfolio delta.
The breakdown shown in Figure 6, Panel B, however, does not allow us to ascertain what
proportion of the average drop in portfolio vega is driven by each of the three components. For example,
does the pre-existing portfolio vega decline at a greater rate or do vega flows accumulate more slowly?
To answer this question, we construct a counterfactual of what the three components would have been
absent the increase in risk. The counterfactual assumes that managers exercise the same number of
options as in year T – 1 and that the pre-existing portfolio vega and the flow vega change at the same rate
as for unexposed firms.
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Relative to this counterfactual, we find that the newly granted compensation’s lower vega
increasingly contributes to the average decline in vega over time. The estimates are displayed in Figure 6,
Panel C. We attribute about a third of the observed drop in CEOs’ portfolio vega three years after the
increase in left-tail risk to the decline in CEOs’ pre-existing portfolio vega, about 60% to the reduction in
annual flows, and about 6% to increased options exercising.22 The relative contribution of each source
varies over time. In the first year, more than half of the decline in portfolio vega is from the CEOs’ preexisting portfolio, while only about one-third is from the flow vega and 10% is from the increased
exercising.
This diminishing role of the pre-existing portfolio suggests that the reduced flow vega and flow
delta have greater impacts over time. Table 3 reports longer-term changes in portfolio vega and portfolio
delta. We find a statistically significant decline in managers’ portfolio delta beginning in year four. In the
fourth year after tail risk increases, the portfolio delta is about $350,000 per 1% increase in equity value
lower for managers of exposed firms relative to other managers and relative to their own deltas before
risk increases (column 4; p < 0.05). This decline is about half of a standard deviation in exposed firms’
portfolio delta. By the fifth year, portfolio delta decreases by about $450,000 per 1% increase in equity
value (column 6; p < 0.10). Beginning in the sixth year after tail risk increases, we also find a statistically
significant decline in portfolio vega. The six-year change in portfolio vega is about $55,000 per 0.01
increase in a firm’s stock volatility, which is about 40% of a standard deviation for exposed firms
(column 7; p < 0.10).

4.3. Effects of exposure on the vega and delta of newly-hired managers
If a manager’s existing portfolio impedes his or her portfolio incentives from adjusting quickly,
then one would expect portfolio incentives for new CEOs to exhibit a different pattern. Because new
CEOs typically enter these positions with relatively small portfolios of company stock and options, their
portfolio incentives should respond quickly after risk increases. To analyze this, we estimate a
The positive contribution of the existing portfolio to the decline in vega indicates that, on average, the increase in
stock volatility and decrease in stock price caused by the increase in left-tail risk cause a drop in the portfolio vega
of exposed CEOs relative to the drop observed for unexposed CEOs. This is consistent with the decline in vega
observed in the theoretical example for a CEO with options (see Figure 2). While not presented in Figure 6, we also
find that the increase in left-tail risk reduces the average delta of CEOs’ pre-existing portfolios.
22
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specification similar to Eq. (2) using only observations from new CEOs’ first year. This estimation
indicates whether Exposure is associated with different initial incentives for new CEOs. Because there are
not many firms with a new CEO in the three years both before and after tail risk increases, we do not
include firm-cohort fixed effects in these specifications. To control for possible baseline differences in the
portfolios of newly hired CEOs in exposed and unexposed industries, we include an indicator variable for
industry-cohorts that experience an increase in tail risk. The results are reported in Table 4.
After tail risk increases, newly hired CEOs are given compensation portfolios that exhibit lower
exposure to firm risk. The portfolio vega is almost $50,000 lower, or about a third of a standard deviation,
for a 0.01 increase in the standard deviation of stock returns for newly hired CEOs of exposed firms
relative to other newly hired CEOs (column 1; p < 0.10). The lower portfolio vega is robust to controlling
for firm size, cash compensation, and CEO tenure (column 2; p < 0.10).
After risk increases, new CEOs of exposed firms are also paid with lower vegas than are the
CEOs they replaced. To examine within-firm changes, we compare the portfolio vega of the new CEO
with that of the prior CEO. Columns 3 and 4 of Table 4 present results for the difference in portfolio vega
between the new CEO and the prior CEO. After controlling for changes in firm size, cash compensation,
and CEO tenure, the portfolio vega of a newly hired CEO of an exposed firm is about $85,000, or almost
two-thirds of a standard deviation, lower than that of the previous CEO, relative to the change at
unexposed firms (column 4; p < 0.10).
5. How the structure of managerial compensation affects corporate risk-taking
Our finding that CEOs’ portfolios respond to changes in firms’ risk environment highlights a key
challenge in identifying a causal effect of incentives on corporate risk-taking. A correlation between
managers’ portfolio convexity and firm risk could reflect the effect of the convexity on managers’ risktaking or it might reflect the effect of firms’ background risk on boards’ choices regarding pay.
The unanticipated increase in tail risk provides an opening to overcome this identification
challenge. To the extent that managers are motivated by financial incentives, portfolio vega and portfolio
delta affect responses to the increase in risk. As shown in Section 2.2, risk-averse managers with convex

25

payoff structures will have less to gain from reducing risk since doing so will also decrease the expected
value of their convex payoffs. Using the ex ante vega as a proxy for the (unobserved) vega managers face

after risk increases but before they respond, we are able to identify an effect of convexity on risk-taking
incentives that avoids the reverse causality critique.23
To analyze the relationship between incentives and risk-taking, we augment our estimation
framework to allow for a differential effect of exposure based on managers’ portfolio vega and portfolio
delta in the year before tail risk increases. Given the persistence of portfolio vega and portfolio delta (see
section 4.2), we focus on a short window of three pre-risk and three post-risk years, and exclude any firmyears after a CEO turns over to ensure the pre-determined compensation structure is a valid proxy for the
ex post incentives. Specifically, we estimate the following firm-panel regression:
yijct  0  1 Exposure jct  2 Exposure jct   Vegaijc[ t T 1] 
 3 Exposure jct    Deltaijc[ t T 1]   tc   ic   ijct ,

(5)

where yijct is one of several dependent variables of interest related to corporate risk-taking, Vegaijc[t=T – 1]
and Deltaijc[t=T – 1] correspond to managers’ portfolio delta and portfolio vega in the year prior to tail risk
increasing, and Exposure and the various fixed effects are defined as above. To ease the interpretation of
the estimates, Vegaijc[t=T

– 1]

and Deltaijc[t=T

– 1]

are normalized by their sample standard deviations and

demeaned with respect to their sample means before they are interacted with Exposure (i.e.,
 ( X )  ( X   X ) /  X ). Therefore, λ1 represents the effect of exposure on a firm with average portfolio

vega and average portfolio delta, and λ2 (λ3) represents the incremental effect of exposure for a standard
deviation increase in vega (delta). The standard errors are again adjusted for clustering at the industry
level.
We include both vega and delta in the specification to disentangle option grants’ competing
effects on risk-taking incentives. On one hand, options’ convex payoffs can encourage risk-taking
because the manager shares all of the gains with shareholders but not all of the losses (Jensen and
Meckling, 1976; Myers, 1977; Smith and Stulz, 1985; Haugen and Senbet, 1981; Smith and Watts, 1992;
We cannot directly observe the incentives immediately after the increase in left-tail risk because we only observe
the year, and not the exact day, in which left-tail risk increases.
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Gaver and Gaver, 1993; Bizjak et al., 1993; Guay, 1999; Core and Guay, 1999). Vega—the sensitivity to
stock volatility—provides a measure of this convexity. On the other hand, holding options also increases
a manager’s sensitivity to stock price movements—delta—and to the firm’s tail risk, which can
discourage risk-taking (Lambert et al., 1991; Carpenter, 2000; Ross, 2004). Because the portfolio vega
and portfolio delta are likely to be positively correlated, a failure to control for a manager’s portfolio delta
may confound the effect we are interested in—the effect of options-based convexity on risk-taking after
the increase in tail risk.
The inclusion of firm-cohort fixed effects,  ic , controls for time-invariant factors, like the
managers’ risk tolerance, that might be correlated with the predetermined levels of vega and delta.
Because we exclude observations after CEOs exit, these fixed effects also effectively control for manager
fixed effects. We do not report estimates for the main effects, Vegaijc[t=T – 1] or Deltaijc[t=T – 1], because they
are, by construction, time-invariant and perfectly collinear with the firm-cohort fixed effects. The
coefficient on Exposurejct×Vegaijc[t=T – 1] captures the differential response for high-vega versus low-vega
exposed firms relative to the similar differential response for unexposed firms. The Exposurejct×

Deltaijc[t=T – 1] coefficient has an analogous interpretation.
We first examine stock variance as a summary measure of firms’ risk-taking. A firm’s stock
variance captures both exposed firms’ increase in tail risk and any corporate choices, such as lower
leverage and fewer R&D expenditures, that offset this increase in risk. The estimates are reported in Table
5. On average, the increase in tail risk is associated with a 0.10 increase in variance for firms with an
exposure (column 1). The increase is large in magnitude (almost half of the sample mean and about a
third of the sample standard deviation) and statistically significant when we add time-varying controls for
firms’ size, leverage, R&D expenditures, and market-to-book ratio (column 3; p < 0.10).24
The increase in firms’ risk is significantly larger among firms whose manager had a high
portfolio vega before the increase in left-tail risk. A one standard deviation increase in a manager’s
portfolio vega is associated with a 0.05 larger increase in stock variance after a chemical is added to the
The sample mean stock variance is 0.23 with a standard deviation of 0.29. The sample mean stock volatility,
another measure of firms’ risk, is 0.42 with a standard deviation of 0.22. These summary statistics are similar to
those of the samples analyzed in other papers (e.g., Hayes et al., 2012).
24

27

RoC. Given that there is no reason to expect the increase in liability and regulatory risk from workplace
exposures to be larger for firms with a higher ex ante vega, this finding suggests that managers with more
convex payoffs are less likely to take actions to offset the unanticipated increase in left-tail risk.
The larger increase in firms’ risk among managers with a high portfolio vega appears to result
from a smaller reduction in financial and investment risk following the increase in tail risk. In analysis
reported in Table 6, we examine firms’ leverage and cash management policies as a function of their
managers’ incentives. The increase in tail risk is associated with a reduction in leverage for the average
firm (column 1), but the decline is only statistically significant for firms with a low vega manager;25 a one
standard deviation increase in a manager’s portfolio vega is associated with about a 1 percentage point
smaller reduction in leverage (column 2; p < 0.10).
Firms’ cash holdings also exhibit a differential response based on the convexity of managers’
payoffs. For the average firm, the increase in tail risk is associated with an increase in the ratio of cash to
assets (column 4; not statistically significant), and a lower portfolio vega is associated with a larger
increase in cash holdings (column 5; p < 0.01). This differential buildup in cash is robust to including
controls for firms’ size, leverage, R&D expenditures, and market-to-book ratio (column 6), but the
differential response in leverage is no longer statistically significant with controls for firms’ size,
profitability, and R&D expenditures, and property, plant, and equipment (column 3).26 The association
between portfolio delta and risk-taking after the increase in tail risk is the opposite. A higher delta is
associated with a larger reduction in leverage (columns 2–3) and larger increase in cash holdings
(columns 5–6).27
Firms’ investment policies also appear to be affected by the CEO’s portfolio incentives. In
analysis reported in Table 7, we examine firms’ research and development expenditures and acquisition
Gormley and Matsa (2011) find that the decline in leverage is statistically significant for the average Compustat
firm. The estimate here is not statistically significant because our sample size is considerably smaller, as our analysis
also requires data on the CEOs’ compensation portfolios.
26
Again, our choice of controls in all specifications follows Hayes et al. (2012). Still, caution is warranted when
interpreting estimates from specifications that include these endogenous controls, because their inclusion can
confound the true causal effect (see footnote 18).
27
The findings for portfolio delta are consistent with Gormley and Matsa (2011), who find that larger inside
ownership, as measured by the fraction of shares owned by top managers, is associated with greater risk-reducing
activities after tail risk increases.
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behavior. The results further highlight the importance of convexity. We find that the increase in tail risk is
only weakly associated with a reduction in the ratio of R&D expenses to assets for the average firm, but a
lower portfolio vega is strongly associated with a larger reduction in R&D expenses (column 2; p < 0.01).
We also find that the portfolio vega is negatively associated with making diversifying acquisitions after
risk increases. Gormley and Matsa (2011) find diversifying acquisitions to be a primary way firms reduce
risk after such an event. Managers with a one standard deviation higher portfolio vega are 2.5 percentage
points less likely to make a diversifying acquisition each year after tail risk increases. Both of the
differential responses in R&D and diversifying acquisitions are robust to including additional timevarying controls (columns 3 and 6; p < 0.01) and are consistent with options’ convex payoffs making
CEOs less aggressive in cutting back on risky investments (such as R&D) and in increasing risk-reducing
investments (such as diversifying acquisitions) after the jump in tail risk.
One possible concern with these results is that an omitted variable could be related to both a
manager’s ex ante incentive structure in the year before risk increases and the firm’s response afterward.
Our analysis of managers’ compensation structures prior to the jump in tail risk relies on the assumption
that the differences in compensation contracts, among firms which are otherwise comparable (as shown in
Table 1), are not driven by factors that also affect firms’ responses to the increase in risk. Contracts will
differ between comparable firms because these contracts are chosen to satisfy many objectives in addition
to setting incentives for risk-taking. For example, some firms may choose to grant more options for
accounting reasons (Hayes et al., 2012). These other objectives provide ex ante variation in incentives that
we exploit. But if factors correlated with these objectives also affect firms’ response to a jump in risk,
then our analysis might suffer from an omitted variable bias.
We evaluate a wide range of potential omitted variables, including corporate financial
vulnerability, external governance, and CEO age and tenure. Gormley and Matsa (2011) find that firms
with greater ex ante bankruptcy risk (as measured by Altman’s z-score), smaller size, more leverage,
lower cash flows, and no dividends are more likely to engage in diversifying growth after tail risk
increases, presumably because these firms experience larger increases in the likelihood of distress.
Gormley and Matsa also find differences related to firms’ external governance, including the proportion
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of institutional ownership. If these factors are related to the initial choice of compensation structure, then
they—rather than incentives from the compensation—might possibly explain our findings. For example,
older and more seasoned executives may be better equipped to cope with a major shock to the firm’s cash
flows; perhaps it is simply these CEOs for which we see no meaningful risk-reducing activities?
To examine the sensitivity of our results to these possible omitted variables, we repeat our
analysis of Eq. (5) for stock variance, cash, leverage, R&D, and diversifying acquisitions but now include
additional interactions between Exposure and the aforementioned list of potential omitted variables.
Specifically, we include interactions between Exposure and firms’ size, leverage, modified Altman’s zscore, cash flows, institutional ownership, CEO tenure, CEO age, and an indicator for paying dividends;
similar to the portfolio vega and portfolio delta, each of the interacted variables is measured as of the year
prior to the increase in tail risk. The estimates are reported in Table 8.
There is no evidence that these potential omitted variables explain the observed correlation
between portfolio vega and risk-taking activities following the jump in tail risk. A higher portfolio vega is
still associated with larger increases in overall firm risk, as measured by stock variance (column 1; p <
0.10), a smaller increase in cash holdings (column 2; p < 0.01) and diversifying acquisitions (column 5; p
< 0.01), and a smaller reduction in leverage (column 3; p < 0.10) and R&D (column 4; p < 0.01).
A final possibility, which we cannot completely control for directly, is that unobservable
differences in managerial risk preferences explain the differential effect of vega on risk-taking. For
example, it is possible that risk-tolerant managers match with riskier firms that also happen to provide
more convex payoff schemes (Graham et al., 2013). If true, then it is possible that the underlying risktolerance of the CEO, rather than convexity of his or her incentives, explains the importance of portfolio
vega for the observed responses.
Although we cannot rule out this possibility definitively, there are indications that it is unlikely to
explain our findings. The robustness tests in Table 8 already allow for a differential effect of Exposure
based on various measures of firm risk, including leverage, Altman’s z-score, and dividends. If the
interaction between vega and Exposure is being driven by some matching of risk-tolerant managers to
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riskier firms, then we would expect these additional interactions to dampen the effect of vega; they do
not. Moreover, theory suggests that the optimal contract for managers with greater risk aversion is
actually more convex so as to provide incentives for the agent to take on appropriate risk on behalf of the
more risk-tolerant shareholders (see, e.g., Guay, 1999). If true and if unobservable risk preferences were
driving our observed responses, we would expect to find vega associated with more risk-reducing
activities after tail risk increases. Instead, we observe the opposite.
6. Conclusions and implications
Every firm is exposed to business risks, including the possibilities of large, adverse shocks to
cash flows. Potential sources for such shocks abound—examples include disruptive product innovations,
the relaxation of international trade barriers, and changes in government regulations. We study (1) how
boards adjust CEOs’ exposure to their firms’ risk after the risk of such shocks increase and (2) how
incentives given by the CEOs’ pre-existing portfolios of stock and options affect their firms’ response to
this risk. Specifically, we study what happens when a firm learns that it is exposing workers to
carcinogens, which increase the risks of significant corporate legal liability and costly workplace
regulations.
The results presented in this paper suggest that corporate boards respond quickly to changes in
their firms’ business risk by adjusting the structure of CEOs’ compensation, but that the changes only
slowly impact the overall portfolio incentives CEOs face. After the unexpected increase in left-tail risk,
corporate boards reduce CEOs exposure to their firms’ risk; the sensitivities of the flow of managers’
annual compensation to stock price movements and to return volatility decrease. Various factors likely
contribute to the board’s decision, including CEOs’ reduced willingness to accept a large exposure to
their firms’ risk and the decline in shareholders’ desired investment after left-tail risk increases. Indeed,
managers act to further reduce their exposure to the firm’s risk by exercising more options than do
managers of unexposed firms. These changes, however, only slowly move CEOs’ overall exposure to
their firm’s risk because the magnitude of their pre-existing portfolios continues to influence their
financial exposure to the firm.
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The unanticipated increase in business risk also provides an opportunity to analyze options’
causal effect on corporate risk-taking. We use CEOs’ pre-existing portfolio of options and stock as a
proxy for managers’ portfolio immediately after the carcinogens’ discovery; these incentives are predetermined with respect to the new risk environment and not subject to the reverse causality concerns that
plague existing studies of compensation structure and risk. We find that CEOs with more convex payoffs
tend not to offset the unexpected increase in risk through diversifying acquisitions, reducing leverage,
cutting R&D expenditures, or by building up greater cash holdings. As a result, stock variance increases
the most for high vega firms after the jump in tail risk. The findings are robust to numerous robustness
checks and do not appear to be driven by omitted factors that might affect both the choice of
compensation and firms’ responses to the increased risk.
Overall, our results show that options affect corporate risk-taking and highlight the importance of
a board structuring its executives’ compensation packages to induce the desired level of risk taking. In
addition, our results imply the novel insight that boards should design the convexity of managers’
compensation with an eye on potential changes in the company’s risk environment and how their
executives will respond given their compensation. As our findings illustrate, more convex payoffs can
dampen managerial incentives to offset unanticipated increases in business risk. Boards interested in
encouraging more aggressive responses to future increases in business risk should use less convex
payoffs, whereas other boards should use more convex payoffs if responding to increases in business risk
is costly and undesirable to shareholders.

Appendix A. Variable definitions
<Insert Appendix Table A.1 here.>

Appendix B. A mean-preserving increase in risk
In the theoretical framework described in Section 2.2, similar changes in the pre-existing
portfolio’s vega and the manager’s differential sensitivities to deviations in risk result if we model the
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increase in risk as a mean-preserving increase in stock price volatility rather than as an increase in left-tail
risk. The portfolio vega after a mean-preserving increase in risk is plotted in Fig. B.1 for both portfolios,
and the manager’s marginal utility with respect to stock return volatility is plotted in Fig. B.2. The decline
in the options portfolio’s vega is smaller in the mean-preserving case than in the case of left-tail risk, but
the decline is still greater than for the stock portfolio, which does not change (Fig. B.1). Nevertheless,
similar to left-tail risk, an unexpected mean-preserving increase in stock price volatility has a smaller
impact on a manager’s expected utility when the manager holds options rather than stock (Fig. B.2).
The similarity is intuitive. A mean-preserving increase in volatility shifts stock volatility to the
right along the expected utility curve (plotted in Figure 1), whereas the increase in left-tail risk, by
reducing the expected cash flows, also shifts the manager’s expected utility curve to the left. In this
regard, the expected marginal utilities after each increase in risk reflect similar mappings of the utility
curve’s slope around the manager’s optimal volatility. The difference in marginal utilities also suggests
that, when a firm sets a new compensation contract, the aggressiveness with which the manager will
implement the implied level of risk-taking depends on the structure of the compensation contract.

Appendix C. Decomposing changes in portfolio vega
In Section 4.2, we report estimates that decompose the changes in exposed CEOs’ portfolio vega
into three sources: changes in the vega of the pre-existing portfolio, additional vega from new option
grants, and reduced vega from managers’ exercising options. Only the Execucomp sample provides
sufficient information on both existing and newly granted options to compute these estimates. The
estimates are based on the following methodology, which is an extension of Core and Guay (2002).
To calculate the vega of CEOs’ pre-existing portfolio of options (vegapre) in the years after lefttail risk increases, we apply the Core-Guay method to calculate the vega of CEOs’ existing options as of
year T–1 in subsequent years by holding constant the number of options and their exercise prices but
adjusting for changes in their maturity, the risk-free rate, and the firm’s dividend yield, stock price, and
stock volatility. To calculate the vega of CEOs’ option grants after the increase in risk (vegaflow), we
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construct the portfolio that consists of options granted after the increase in tail risk and apply the CoreGuay method to calculate the vega of this portfolio. Lastly, to calculate the vega of options exercised
(vegaexercised), we construct the portfolio of exercised options and again apply the Core-Guay method to
calculate the vega of this portfolio. Because Execucomp only provides the number and value of exercised
options but not their maturity or exercise price, we approximate these inputs by assuming that exercised
options have the same average exercise price and maturity as the CEOs’ exercisable options in the
previous year.
Using the three above calculations, we can reconstruct the CEOs’ overall vega in the years after
the increase in tail-risk. Specifically, the “implied” portfolio vega equals vegapre + vegaflow – vegaexercised.
Despite the approximations required for these calculations, the implied vegas closely track observed
vegas; for the average exposed CEO in our sample, the implied vega differs from the observed vega by
only about 5%.
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Fig. 1. Expected utility as a function of stock variance. This figure plots the expected utility of a
manager as a function of the manager’s portfolio and the variance of the firm’s annual stock returns.
The firm’s stock return is assumed to follow a lognormal process with an initial price of $50 and
annual expected return of 10 percent, and the manager is assumed to have a power utility function
with a coefficient of relative risk aversion of two. The options portfolio contains 50,000 options. The
options are assumed to expire in ten years and have a 20 percent probability of being in the money at
expiration. The stock portfolio contains 2,500 shares of stock. In both cases, the portfolio accounts for
one-third of the manager’s total wealth. A positive affine transformation is used to rescale the level of
expected utility.
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Fig. 2. Portfolio vega after an increase in left-tail risk. This figure plots each portfolio’s vega after an
increase in the probability of a left-tail risk, defined as an increase in the probability of a stock price
realization below $10 at the time the options expire. The portfolio vega is calculated assuming a zero
dividend yield, a risk free rate of five percent, and that the firm was at the manager’s optimal level of
stock volatility prior to left-tail risk increasing.
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Fig. 3. Marginal expected utility of risk after an increase in left-tail risk. This figure plots the manager’s
marginal utility of risk after an increase in the probability of a left-tail risk, defined as an increase in the
probability of a stock price realization below $10 at the time the options expire. This is the numerical
derivative of the manager’s expected utility (shown in Figure 1) with respect to volatility, evaluated at the
manager’s previously optimal level of stock volatility.
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Fig. 4. Stock variance of exposed and unexposed firms. This figure plots the relative average
annualized daily stock variance for exposed and unexposed firms, indexed to one in the year prior to a
chemical being added to the Report on Carcinogens.
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Fig. 5. Effect of exposure on flow vega, flow delta, and the value of options exercised by year. This
figure reports the point estimates from firm-panel regressions of flow vega, flow delta, and the value
of options exercised on an indicator for exposure, firm-by-cohort fixed effects, and year-by-cohort
fixed effects. The specifications are the same as those reported in Table 2, columns 1, 4, and 7, except
that the effect of exposure is allowed to vary by year in event time.
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Fig. 6. Deconstructing exposed managers’ portfolio vega in year T+2. Panel A reports managers’
average portfolio vega in exposed and unexposed firms in the Execucomp sample by year relative to
the increase in tail risk. Panel B deconstructs the overall, average portfolio vega of exposed managers
in year T+2 into its three components: vega from managers’ pre-exposure portfolio, new flows, and
the drop in vega from exercising of options. Panel C plots the percent contribution of each source to
the total drop in year T+2 relative to the counterfactual that exposed managers continue exercising
the same number of options as they did in year T-1 and experience the same growth rate in their preexposure portfolio vega and flow vega as unexposed managers during the same time period.
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Table 1
Ex-ante firm characteristics.
This table reports summary statistics for firm characteristics in the three years before a new
chemical was added to the Report on Carcinogens. The mean and standard deviation (in parentheses)
for each variable are reported separately for two samples of firms. Column 1 reports estimates for
firms in 4-digit SIC industries for which more than 5% of employees were observed to be exposed to
the chemical in the 1981–1983 National Occupational Exposure Survey. Column 2 reports estimates
for other firms in the same Fama-French 48-industry classification. Column 3 reports the p-value
from a t-test of the difference between exposed and unexposed firms, where the standard errors are
adjusted for clustering at the 4-digit SIC industry level. The sample is restricted to firms with nonmissing observations for portfolio vega and delta in the year prior to the new chemical being added to
the Report on Carcinogens.

p ‐value of
difference
(3)

Exposed

Unexposed

(1)

(2)

0.243
(0.211)
7.151
(1.522)
0.026
(0.165)
0.155
(0.088)

0.177
(0.189)
7.438
(1.396)
0.026
(0.063)
0.147
(0.092)

0.350

326.2
(716.0)
41.74
(139.5)
6.972
(0.955)
0.313
(0.311)

519.3
(2,537)
27.60
(112.2)
6.920
(1.011)
0.265
(0.254)

0.299

143
43

341
82

Firm characteristics
Stock variance
Ln(assets)
Market‐to‐book ratio
Cash flows / assets

0.472
0.992
0.419

Compensation characteristics
Portfolio delta
Portfolio vega
Ln(total pay)
Options / total pay
Observations
# of industries
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0.591
0.761
0.562

Table 2
The effect of exposure on flow vega, flow delta, and options exercised.
This table reports coefficients from firm-panel regressions of flow vega, flow delta, and the value of options exercised on an indicator for
exposure, firm-by-cohort fixed effects, and year-by-cohort fixed effects. Exposure equals one if more than 5% of employees in the firm’s 4digit SIC industry were observed to be exposed to a chemical listed in the most recent edition of the Report on Carcinogens (RoC), as reported
in the 1981–1983 National Occupational Exposure Survey. The sample includes firm-year observations in the three years before and three
years after each new chemical listing in the RoC for firms with non-missing portfolio vega and delta in the year prior to the new RoC listing.
Columns 3, 6, and 9 exclude observations after a new chemical listing for which the CEO is different than the CEO in the year prior to the
chemical being listed. Columns 2–3, 5–6, and 8–9 include firms’ Ln(assets) and CEOs’ tenure and salary + bonus as additional controls.
Standard errors, adjusted for clustering at the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5%
level; *significant at 10% level.

Flow vega
Mean = 17.52
St. Dev. = 55.90

Dep. variable =
(1)
Exposure

Observations
2
R
# of firms
Additional controls
Excludes new CEOs after T – 1
Fixed effects:
Firm‐cohort
Year‐cohort

(2)

Flow delta
Mean = 20.37
St. Dev. = 83.06
(3)

‐7.60** ‐10.00*** ‐8.90**
(3.11)
(3.76)
(3.89)
2,378
0.02
469

X
X

1,367
0.05
309

1,211
0.05
264

X

X
X

X
X

X
X

(4)

(5)

‐12.88*** ‐24.61*
(4.70)
(13.67)
2,363
0.01
469

X
X
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Value of options exercised
Mean = 912.9
St. Dev. = 4,546
(6)

‐25.21*
(14.40)

1,367
0.04
309

1,211
0.05
264

X

X
X

X
X

X
X

(7)

(8)

(9)

790.8 1,063*** 1,184***
(575.9) (397.9) (429.2)
2,505
0.02
484

X
X

1,439
0.09
320

1,277
0.10
275

X

X
X

X
X

X
X

Table 3
Long-term effect of exposure on portfolio vega and portfolio delta.
This table reports coefficients from CEO-level regressions of post-exposure changes in portfolio vega and portfolio delta on an indicator for
exposure and cohort fixed effects. Exposure is defined as in Table 2. The sample includes CEOs with non-missing portfolio vega and portfolio
delta in the year prior to the RoC listing and excludes CEOs that are no longer present in the year in which the post-exposure change in
incentives is calculated. The dependent variables are the three-, four-, five-, and six-year changes in portfolio vega and portfolio delta relative
to the year prior to a chemical being added to the RoC. Standard errors, adjusted for clustering at the industry level, are reported in
parentheses. **significant at the 5% level; *significant at 10% level.

Dep. variable =

Exposure

Observations
2
R
Excludes new CEOs after T – 1
Cohort fixed effects

3‐year Δ in incentives
[T+2] versus [T‐1]

4‐year Δ in incentives
[T+3] versus [T‐1]

5‐year Δ in incentives
[T+4] versus [T‐1]

6‐year Δ in incentives
[T+5] versus [T‐1]

Portfolio
vega

Portfolio
delta

Portfolio
vega

Portfolio
delta

Portfolio
vega

Portfolio
delta

Portfolio
vega

Portfolio
delta

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

‐24.60
(26.06)

‐181.7
(132.0)

‐43.71
(27.49)

‐346.4**
(151.8)

‐43.66
(28.35)

‐448.2*
(229.2)

‐55.31*
(28.95)

‐483.8**
(225.1)

334
0.02

334
0.05

262
0.02

262
0.05

251
0.05

251
0.02

218
0.06

218
0.02

X
X

X
X

X
X

X
X

X
X

X
X

X
X

X
X
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Table 4
The effect of exposure on newly hired CEOs’ portfolio vega.
This table reports coefficients from CEO-level regressions of the level of and change in portfolio vega on an indicator for exposure, year-bycohort fixed effects, and an indicator for operating in an industry-cohort with an exposure. Exposure is defined as in Table 2. The sample includes
observations from a CEO’s first year in office for CEOs hired in the three years before and three years after each new chemical listing in the RoC.
To ensure the same sample of firms as in earlier specifications, we continue to restrict the sample to firms with non-missing portfolio vega and
portfolio delta in the year prior to the new RoC listing. The dependent variable in columns 1–2 is the initial portfolio vega of the newly hired
CEO, and the dependent variable in columns 3–4 is the difference between the new CEO’s initial portfolio vega and the portfolio vega of the
outgoing CEO. Column 2 includes firms’ Ln(assets) and the new CEOs’ tenure and salary + bonus as additional controls, and column 4 includes
the changes in these variables as controls. Standard errors, adjusted for clustering at the industry level, are reported in parentheses. *significant at
10% level.

Dep. variable =

Exposure
Observations
2
R
Exposed industry‐cohort indicator
Year‐cohort fixed effects
Additional controls

Portfolio vega of
newly‐hired CEO

Δ portfolio vega
from prior CEO

(1)

(2)

(3)

(4)

‐49.4*
(25.8)

‐30.3*
(17.7)

‐111.5
(67.2)

‐84.6*
(42.3)

175
0.09

149
0.45

167
0.08

71
0.36

X
X

X
X
X

X
X

X
X
X
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Table 5
The effects of exposure and payoff structure on firms’ stock variance.
This table reports coefficients from firm-panel regressions of annualized daily stock variance on
Exposure (an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year
prior to an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. Exposure is
defined as in Table 2. The sample includes firms with non-missing portfolio vega and portfolio delta in
the year prior to the RoC listing and excludes firm-year observations after a new chemical listing for
which the CEO is different than the CEO in the year prior to the chemical being listed. For ease of
interpreting the exposure coefficient and its interactions, the portfolio vega and portfolio delta are
demeaned and rescaled by their sample standard deviation [i.e., φ(X) = (X - μX)/σX] before being
interacted with Exposure. Column 3 includes firms’ Ln(sales), debt/assets, R&D/sales (with missing
values replaced with zeros), and market-to-book ratio as additional controls. Standard errors, adjusted for
clustering at the industry level, are reported in parentheses. **significant at the 5% level; *significant at
10% level.

Stock variance
Mean = 0.23
St. Dev. = 0.29

Dep. variable =
(1)

(2)

(3)

0.102
(0.068)

0.094
(0.059)

0.097*
(0.056)

Exposure × φ(Vega T – 1)

0.049**
(0.019)

0.047**
(0.019)

Exposure × φ(Delta T – 1)

0.023
(0.053)

0.039
(0.050)

2,620
0.22
484

2,620
0.23
484

2,562
0.24
480

X

X

X
X

X
X

X
X

X
X

Exposure

Observations
2
R
# of firms
Excludes new CEOs after T – 1
Additional controls
Fixed effects:
Firm‐cohort
Year‐cohort
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Table 6
The effects of exposure and payoff structure on firms’ financial risk.
This table reports coefficients from firm-panel regressions of debt/assets and cash/assets on Exposure
(an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year prior to
an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. The specification is
the same as in Table 5. For ease of interpreting the exposure coefficient and its interactions, the portfolio
vega and portfolio delta are demeaned and rescaled by their sample standard deviation [i.e., φ(X) = (X μX)/σX] before being interacted with Exposure. The additional controls follow Hayes et al. (2012); in
column 3, they include firms’ Ln(sales), EBITDA/assets, R&D/sales (with missing values replaced with
zeros), and PP&E/assets; and in column 6, they include firms’ Ln(sales), debt/assets, R&D/sales (with
missing values replaced with zeros), and market-to-book ratio. Standard errors, adjusted for clustering at
the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5%
level; *significant at 10% level.

Debt/assets
Mean = 0.25
St. Dev. = 0.17

Dep. variable =

Exposure

(1)

(2)

(3)

(4)

(5)

(6)

‐0.005
(0.012)

‐0.006
(0.013)

‐0.014
(0.011)

0.003
(0.007)

0.004
(0.007)

0.005
(0.007)

0.009*
(0.005)

0.005
(0.004)

Exposure × φ(Vega T – 1 )
Exposure × φ(Delta T – 1 )

Observations
2
R
# of firms
Excludes new CEOs after T – 1
Additional controls
Fixed effects:
Firm‐cohort
Year‐cohort

Cash/assets
Mean = 0.067
St. Dev. = 0.094

‐0.006*** ‐0.006***
(0.002)
(0.002)

‐0.056** ‐0.066***
(0.023) (0.018)

0.021*** 0.019**
(0.006)
(0.008)

2,597
0.03
481

2,597
0.04
481

2,588
0.11
481

2,230
0.04
454

2,230
0.04
454

2,210
0.07
452

X

X

X
X

X

X

X
X

X
X

X
X

X
X

X
X

X
X

X
X
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Table 7
The effects of exposure and payoff structure on investment risk.
This table reports coefficients from firm-panel regressions of R&D/assets and an indicator for
undertaking a diversifying acquisition on Exposure (an indicator for exposure) and its interactions with
portfolio vega and portfolio delta in the year prior to an increase in tail risk, firm-by-cohort fixed effects,
and year-by-cohort fixed effects. The specification is the same as in Table 5. For ease of interpreting the
exposure coefficient and its interactions, the portfolio vega and portfolio delta are demeaned and rescaled
by their sample standard deviation [i.e., φ(X) = (X - μX)/σX] before being interacted with Exposure. The
additional controls follow Hayes et al. (2012); in column 3, they include firms’ Ln(sales), sales growth,
debt/assets, stock return, surplus cash/assets, and market-to-book ratio and CEOs’ salary + bonus; and in
column 6, they include firms’ Ln(sales), EBITDA/assets, debt/assets, stock return, and market-to-book
ratio, CEOs’ tenure and salary + bonus, and a CEO exit indicator. Standard errors, adjusted for clustering
at the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5%
level.

R&D/assets
Mean = 0.049
St. Dev. = 0.048

Dep. variable =

Exposure

(1)

(2)

(3)

(4)

(5)

(6)

‐0.003
(0.002)

‐0.004
(0.002)

‐0.0003
(0.002)

0.024
(0.034)

0.029
(0.036)

0.030
(0.037)

Exposure × φ(Vega T – 1)

0.002*** 0.001***
(0.0002) (0.0003)

Exposure × φ(Delta T – 1)

Observations
2
R
# of firms
Excludes new CEOs after T – 1
Additional controls
Fixed effects:
Firm‐cohort
Year‐cohort

Diversifying acq. indicator
Mean = 0.13
St. Dev. = 0.34

‐0.002
(0.002)

0.006*
(0.005)

1,361
0.06
259

1,361
0.06
259

1,352
0.18
259

X

X

X
X

X
X
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‐0.026*** ‐0.022***
(0.006) (0.008)
0.055**
(0.026)

0.034
(0.035)

2,645
0.02
484

2,645
0.02
484

2,576
0.02
480

X
X

X

X

X
X

X
X

X
X

X
X

X
X

Table 8
Controlling for possible omitted variables.
This table reports coefficients from firm-panel regressions of annualized daily stock variance,
cash/assets, debt/assets, R&D/assets, and an indicator for undertaking a diversifying acquisition on
Exposure (an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year
prior to an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. The
specifications are the same as those reported in Tables 5–7, but also include as controls additional
interactions between Exposure and various CEO and firm characteristics in the year prior to a new RoC
listing. The following characteristics are each interacted separately with Exposure: Ln(assets), a dividend
indicator, debt/assets (except for column 3), modified Altman z-score, cash flows/assets, institutional
ownership, CEO tenure, and CEO age. Standard errors, adjusted for clustering at the industry level, are
reported in parentheses. ***significant at the 1% level; **significant at the 5% level; *significant at the
10% level.

Stock

Cash/
assets

Debt/
assets

R&D/
assets

Diversifying
acquisition

(1)

(2)

(3)

(4)

(5)

‐0.003
(0.019)

0.005
(0.003)

0.057
(0.052)

Dep. variable = variance

Exposure

0.147*** 0.0221**
(0.040)
(0.011)

Exposure × φ(Vega T – 1)

0.026* ‐0.006*** 0.007*
(0.015)
(0.002)
(0.004)

Exposure × φ(Delta T – 1)

0.039
(0.043)

Observations
2
R
# of firms

1,393
0.35
253

1,287
0.06
246

1,403
0.07
253

772
0.10
144

1,403
0.06
253

X
X

X
X

X
X

X
X

X
X

X
X

X
X

X
X

X
X

X
X

Excludes new CEOs after T – 1
Additional Exposure interactions
Fixed effects:
Firm‐cohort
Year‐cohort

0.002*** ‐0.033***
(0.000)
(0.008)

0.0213** ‐0.075*** 0.001
(0.009)
(0.021)
(0.002)
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0.056
(0.044)

Table A.1
Variable Definitions

Dependent variables
Portfolio delta

Manager’s change in wealth (expressed in thousands of dollars) for a 1% increase in the firm’s stock price. Calculated
from managers’ complete portfolio of stock and options from Execucomp or Yermack (1995) using the methodology
from Core and Guay (2002). The value of the option portfolio is the sum of the Black‐Scholes values of the newly
granted options and previously granted unexercisable and exercisable options. The Yermack sample contains
information on a manager’s previously granted stock but not options, so we use information only on options granted in
the last year to calculate the managers’ options’ delta.

Portfolio vega

Manager’s change in wealth (expressed in thousands of dollars) for a 0.01 increase in the annualized standard
deviation of firm’s stock returns. Calculated from managers’ complete portfolio of stock and options from Execucomp
or Yermack (1995) using the methodology from Core and Guay (2002). See the definition of Portfolio delta for more
detail.
Same as Portfolio delta but calculated using only stocks and options granted in given year. In the Execucomp sample,
the number of shares granted is approximated using rstkgrnt/prccf, and in the Yermack sample, it is approximated
using othcomp/endprice.

Flow delta

Flow vega

Same as Portfolio vega but calculated using only options granted in given year.

Value exercised

Calculated as opt_exer_val in the Execucomp sample and as optgains in the Yermack sample.

Cash/assets

Calculated from Compustat using ch/at.

Debt/assets

Calculated from Compustat using (dltt + dlc)/at.

Diversifying
Calculated using SDC's Mergers and Acquisitions Database. The indicator equals one if the firm undertakes an
acquisition indicator acquisition where its primary SIC industry does not coincide with any SIC code of the target firm.
R&D/assets

Calculated from Compustat using xrd/at.

Stock variance

Calculated from CRSP using the sum of squared daily returns over the year. To adjust for differences in the number of
trading days, the raw sum is multiplied by 252 and divided by the number of trading days.

52

Firm‐level controls (from Compustat)
Cash flows/assets

(oiadp – accruals) / at, where accruals = (actt – actt‐1) – (chet – chet‐1) – (lctt – lctt‐1) + (dlct – dlct‐1) – dp

EBITDA/assets

oibdp/at

Ln(assets)

ln(at)

Ln(sales)

ln(sale)

Market‐to‐book ratio

(csho * prcc_c)/ceq

PP&E/assets

ppent/at

R&D/sales

min(0, xrd/sale)

Sales growth

ln(salet) ‐ ln(salet‐1)

Surplus cash/assets

(oancf – dpc + xrd) / at

Firm‐level controls (from CRSP)
Stock return

Calendar‐year total stock return, compounded from monthly holding period returns where ordinary dividends are
reinvested at month‐end.

CEO‐level controls
CEO age

Age of CEO obtained from Disclosure database between 1990 and 2004, provided by James S. Linck.

CEO tenure

Number of years a manager has been CEO, which is obtained from Disclosure database between 1990 and 2004,
provided by James S. Linck. Missing values are imputed when possible.

CEO exit

Indicator that equals one in the year that a CEO turns over.

Ln(total pay)

Calculated as ln(tdc1) in the Execucomp sample and ln(salbon + othcomp + grantval) in the Yermack sample.

Options/total pay

Calculated as option_awards_blk_value/tdc1 in the Execucomp sample and grantval / (salbon + othcomp + grantval)
in the Yermack sample.

Salary + bonus

Calculated as salary + bonus in the Execucomp sample and salbon in the Yermack sample.

Note: All variables that represent a dollar value, including delta and vega, are adjusted for inflation using the annual average CPI index for
urban consumers from the Bureau of Labor Statistics.
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Portfolio vega

31.2
Options
Options
31.0

Stock
0
0

0.02

0.04

0.06

0.08

0.10

Deviation from optimal stock variance
Fig. B.1. Portfolio vega after a mean-preserving increase in risk. This figure plots each portfolio’s vega
after a mean-preserving increase in stock variance. The portfolio vega is calculated assuming a zero
dividend yield, a risk-free rate of five percent, and that the firm was at the manager’s optimal level of
stock volatility prior to risk increasing.
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Marginal expected utility with respect to risk

0

‐10

‐20

Options

‐30

Stock
0

0.02

0.04

0.06

0.08

0.10

Deviation from optimal stock variance
Fig. B.2. Marginal expected utility of risk after a mean-preserving increase in risk. This figure plots the
manager’s marginal utility of risk after a mean-preserving increase in stock variance. This is the
numerical derivative of the manager’s expected utility (shown in Figure 1) with respect to variance at
points above the manager’s previously optimal level of stock variance.
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